当前位置:首页 - 行情中心 - 博迅生物(920504) - 财务分析

博迅生物

(920504)

  

流通市值:3.62亿  总市值:9.17亿
流通股本:1709.19万   总股本:4333.31万

博迅生物(920504)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.01亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益20790.19万元,未分配利润2976.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产26233.19万元,负债5443.00万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入26,599,005.35119,810,751.5584,576,132.6452,515,393.67
营业总成本24,273,581.88107,019,235.2275,863,313.6147,789,310.23
其他经营收益
营业利润1,742,639.9116,747,348.8610,066,365.734,192,679.04
利润总额1,742,876.0716,336,245.589,668,471.393,937,732.2
净利润1,495,622.0114,914,704.148,543,763.953,636,385.82
每股收益
其他综合收益----
综合收益总额1,495,622.0114,914,704.148,543,763.953,636,385.82
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计163,957,724.81171,677,640.37151,506,224.11153,480,064.2
非流动资产:
非流动资产合计98,374,181.1199,682,154.61103,529,931.1391,801,373.08
资产总计262,331,905.92271,359,794.98255,036,155.24245,281,437.28
流动负债:
流动负债合计35,658,453.3846,211,887.4534,994,896.4730,109,802.65
非流动负债:
非流动负债合计18,771,532.4818,741,609.4820,005,900.9120,043,654.9
负债合计54,429,985.8664,953,496.9355,000,797.3850,153,457.55
所有者权益(或股东权益):
归属于母公司股东权益合计207,901,920.06206,406,298.05200,035,357.86195,127,979.73
股东权益合计207,901,920.06206,406,298.05200,035,357.86195,127,979.73
负债和股东权益合计262,331,905.92271,359,794.98255,036,155.24245,281,437.28
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计11,324,417.81115,269,940.9161,234,288.7830,470,210.91
经营活动现金流出小计24,749,263.9894,723,025.3664,751,219.3442,087,430.39
经营活动产生的现金流量净额-13,424,846.1720,546,915.55-3,516,930.56-11,617,219.48
投资活动产生的现金流量:
投资活动现金流入小计77,343,759.7329,980,566.24229,808,342.95143,430,387.21
投资活动现金流出小计106,582,722.59348,410,396.4258,328,348.29176,294,385.87
投资活动产生的现金流量净额-29,238,962.89-18,429,830.16-28,520,005.34-32,863,998.66
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计-2,826,3032,279,9992,279,999
筹资活动产生的现金流量净额--2,826,303-2,279,999-2,279,999
汇率变动对现金及现金等价物的影响-23,198.22964.769,877.34,253.36
现金及现金等价物净增加额-42,687,007.28-708,252.85-34,307,057.6-46,756,963.78
期末现金及现金等价物余额33,037,871.0575,724,878.3342,126,073.5829,676,167.4
补充资料:
现金及现金等价物的净增加额--708,252.85--46,756,963.78
TOP↑